LPL Financial’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Buy |
24,246
+1,112
| +5% | +$116K | ﹤0.01% | 2888 |
|
|
2025
Q1 | $2.7M | Sell |
23,134
-1,075
| -4% | -$125K | ﹤0.01% | 2670 |
|
|
2024
Q4 | $2.05M | Buy |
24,209
+7,837
| +48% | +$663K | ﹤0.01% | 2827 |
|
|
2024
Q3 | $1.47M | Buy |
16,372
+1,491
| +10% | +$134K | ﹤0.01% | 2985 |
|
|
2024
Q2 | $1.2M | Sell |
14,881
-1,154
| -7% | -$92.9K | ﹤0.01% | 3049 |
|
|
2024
Q1 | $1.28M | Buy |
16,035
+5,640
| +54% | +$450K | ﹤0.01% | 2932 |
|
|
2023
Q4 | $827K | Buy |
10,395
+1,896
| +22% | +$151K | ﹤0.01% | 3183 |
|
|
2023
Q3 | $594K | Sell |
8,499
-99
| -1% | -$6.92K | ﹤0.01% | 3308 |
|
|
2023
Q2 | $618K | Sell |
8,598
-50
| -0.6% | -$3.59K | ﹤0.01% | 3222 |
|
|
2023
Q1 | $533K | Buy |
8,648
+1,014
| +13% | +$62.5K | ﹤0.01% | 3254 |
|
|
2022
Q4 | $589K | Sell |
7,634
-1,711
| -18% | -$132K | ﹤0.01% | 3087 |
|
|
2022
Q3 | $417K | Buy |
9,345
+487
| +5% | +$21.7K | ﹤0.01% | 3297 |
|
|
2022
Q2 | $339K | Sell |
8,858
-1,453
| -14% | -$55.6K | ﹤0.01% | 3509 |
|
|
2022
Q1 | $427K | Sell |
10,311
-1,984
| -16% | -$82.2K | ﹤0.01% | 3307 |
|
|
2021
Q4 | $465K | Buy |
12,295
+1,079
| +10% | +$40.8K | ﹤0.01% | 3326 |
|
|
2021
Q3 | $370K | Buy |
11,216
+7,353
| +190% | +$243K | ﹤0.01% | 3463 |
|
|
2021
Q2 | $261K | Buy |
+3,863
| New | +$261K | ﹤0.01% | 3679 |
|